System and method for assessing cognitive function and measuring treatment efficacy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090081626A1
SERIAL NO

11453563

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Embodiments of the invention described herein relate generally to a method for assessing cognitive function and measuring treatment efficacy. Assessing the efficacy of clinical treatments is important for development of new interventions, for example drugs, gene, protein or antibody therapies, as well as for monitoring patient responses to approved and prescribed therapies. It is feasible to use modified versions of tests developed for experimental animals, such as primates or canines, to evaluate cognition in humans. Because the tasks are non-verbal, individuals with severely limited cognitive abilities can be objectively evaluated. Inferences can be made about the human neuropathology because the neural substrates underlying the ability to perform these tasks in animals have been delineated.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CANCOG TECHNOLOGIES INCTORONTO ON M5A4K2

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Araujo, Joseph Toronto, CA 20 95
Milgram, William Toronto, CA 2 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation